Prelude Therapeutics Newsroom

Prelude Therapeutics (PRLD) Gets a Sell From Morgan Stanley

TipRanksDec 12 05:31 ET

Morgan Stanley Maintains Prelude Therapeutics(PRLD.US) With Sell Rating

Moomoo NewsDec 12 05:31 ET

Prelude Therapeutics Analyst Ratings

BenzingaDec 11 12:24 ET

JMP Securities Maintains Prelude Therapeutics(PRLD.US) With Buy Rating, Cuts Target Price to $4

Moomoo NewsDec 11 00:33 ET

Prelude Therapeutics Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow JonesNov 8 11:54 ET

Barclays Maintains Prelude Therapeutics(PRLD.US) With Sell Rating, Maintains Target Price $1

Moomoo NewsNov 8 05:33 ET

Prelude Therapeutics (PRLD) Receives a Sell From Barclays

TipRanksNov 8 04:53 ET

Prelude Therapeutics: Promising Developments and Strategic Collaborations Drive Buy Rating

TipRanksNov 7 00:37 ET

JMP Securities Maintains Prelude Therapeutics(PRLD.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsNov 7 00:33 ET

Prelude Therapeutics Analyst Ratings

BenzingaOct 28 08:11 ET

H.C. Wainwright Maintains Prelude Therapeutics(PRLD.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsOct 28 06:34 ET

Barclays Maintains Prelude Therapeutics(PRLD.US) With Sell Rating, Maintains Target Price $1

Moomoo NewsOct 28 05:35 ET

Barclays Maintains Prelude Therapeutics(PRLD.US) With Sell Rating, Cuts Target Price to $1

Moomoo NewsOct 26 12:31 ET

Cautious Outlook on Prelude Therapeutics: Sell Rating Amid Modest Trial Results and Market Skepticism

TipRanksOct 25 06:32 ET

JMP Securities Maintains Prelude Therapeutics(PRLD.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsOct 25 00:31 ET

Buy Rating Affirmed for Prelude Therapeutics Amid Positive Developments in PRT3789 and Strong Financial Position

TipRanksOct 25 00:30 ET

Prelude Therapeutics Price Target Announced at $5.00/Share by HC Wainwright & Co.

Dow JonesSep 19 07:38 ET

H.C. Wainwright Upgrades Prelude Therapeutics(PRLD.US) to Buy Rating, Maintains Target Price $5

Moomoo NewsSep 19 06:31 ET

Prelude Therapeutics Analyst Ratings

BenzingaSep 16 07:08 ET

H.C. Wainwright Maintains Prelude Therapeutics(PRLD.US) With Hold Rating, Maintains Target Price $5

Moomoo NewsSep 16 06:33 ET